Cargando…
Nocodazole Treatment Decreases Expression of Pluripotency Markers Nanog and Oct4 in Human Embryonic Stem Cells
Nocodazole is a known destabiliser of microtubule dynamics and arrests cell-cycle at the G2/M phase. In the context of the human embryonic stem cell (hESC) it is important to understand how this arrest influences the pluripotency of cells. Here we report for the first time the changes in the express...
Autores principales: | Kallas, Ade, Pook, Martin, Maimets, Martti, Zimmermann, Külli, Maimets, Toivo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084750/ https://www.ncbi.nlm.nih.gov/pubmed/21559451 http://dx.doi.org/10.1371/journal.pone.0019114 |
Ejemplares similares
-
SOX2 Is Regulated Differently from NANOG and OCT4 in Human Embryonic Stem Cells during Early Differentiation Initiated with Sodium Butyrate
por: Kallas, Ade, et al.
Publicado: (2014) -
Assessment of the Potential of CDK2 Inhibitor NU6140 to Influence the Expression of Pluripotency Markers NANOG, OCT4, and SOX2 in 2102Ep and H9 Cells
por: Kallas, Ade, et al.
Publicado: (2014) -
Lovastatin Decreases the Expression of CD133 and Influences the Differentiation Potential of Human Embryonic Stem Cells
por: Kallas-Kivi, Ade, et al.
Publicado: (2016) -
Changes in Laminin Expression Pattern during Early Differentiation of Human Embryonic Stem Cells
por: Pook, Martin, et al.
Publicado: (2015) -
The role of integrin β1 in the heterogeneity of human embryonic stem cells culture
por: Kallas-Kivi, Ade, et al.
Publicado: (2018)